- CEO
- Xin Qian
- Full Time Employees
- 811
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- No.1 Fenghuang South Road Zhangjiagang JS China 215613
- IPO Date
- Jan 28, 2021
- Business
- Jiangsu Feymer Technology Co., Ltd. Jiangsu Feymer Technology Co., Ltd. (688350.SS) is a China-based high-tech enterprise specializing in the research, development, production, and sales of water-soluble polymers and related solutions for water resource utilization, protection, and treatment in water-borne industries. Founded in 2010 and headquartered in Zhangjiagang City, Jiangsu Province, the company offers core products including functional monomers such as acrylamide, diallyldimethylammonium chloride, allyltrimethylammonium chloride, and methacrylamidopropyltrimethylammonium chloride; water treatment chemicals for sludge treatment, wastewater recycling, and ultra-low emissions; industrial water processing chemicals for pulp and paper, mineral processing, oil and gas extraction, textile printing and dyeing, steel, petrochemical, and emerging sectors; water treatment membranes encompassing MBR, ultrafiltration (UF), nanofiltration (NF), and reverse osmosis (RO) types; and membrane application technologies, water treatment engineering, and operational services, along with external supplies of hydrogen, steam, and electricity. Jiangsu Feymer Technology Co., Ltd. operates three major production bases in Zhangjiagang and Nantong, Jiangsu, and Anqing, Anhui, with over 200,000 tons annual chemical capacity and 6 million square meters of membrane production, serving domestic and overseas markets including municipal, industrial, agricultural, mining, and textile customers, while maintaining 290 authorized patents as of 2024 including 117 invention patents and investing heavily in R&D. In recent developments, Everrising Holdings Limited completed the acquisition of a 29.98% stake from Jiangsu Feixiang Chemical Co., Ltd. in April 2025 for approximately CNY 600 million; Feymer Technology (Anhui) Co., Ltd. announced trial production commencement in May 2025 for its Phase I project with 225,000 tons annual water-soluble polymers and 220,000 tons functional monomers capacity; the company updated its brand identity in May 2025; and it added 52 new patents in 2024 while hosting visits from key industry leaders like Shagang Group in June 2025 to explore strategic collaborations.